Navigation Links
Perrigo Closes Acquisition of Paddock Labs
Date:7/26/2011

ALLEGAN, Mich., July 26, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has closed the acquisition of Paddock Laboratories, Inc. ("Paddock"), a privately-held, Minneapolis-based pharmaceutical manufacturer of generic Rx pharmaceuticals and OTC specialty products for approximately $540 million in cash.

Perrigo Chairman and CEO Joseph C. Papa stated, "We are very pleased to welcome the Paddock team to the Perrigo family. This acquisition is another important step forward in executing Perrigo's strategy to expand our specialty portfolio of generic Rx products. It adds incremental scale, as well as excellent development and manufacturing capabilities across a spectrum of niche dosage forms. It solidifies Perrigo's leading position in the extended topical space and strengthens our ability to offer new products into the market. Paddock has a proven record for quality manufacturing with great customer service."

As previously highlighted, Perrigo expects to receive a significant tax benefit generated from the acquisition of Paddock's assets. The net present value of the tax benefit is estimated to be $95 million. Inclusive of the tax benefit, the total consideration for the acquisition is approximately $445 million.

As a result of the closing of the acquisition, Watson Pharmaceuticals, Inc. (NYSE: WPI) will acquire a portfolio of generic pharmaceutical products from Perrigo that are being divested as a result of the FTC review. The total revenues from marketed products represent less than 0.2% of the combined entities' total FY11 revenues, and none of the revenues from the divested pipeline product were included in Perrigo's projections for the next few fiscal years. Terms were not disclosed.

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) ph
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Perrigo Announces Approval for Over-the-Counter Childrens Cetirizine Oral Solution
2. Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
3. Perrigo Announces FDA Final Approval for Polyethylene Glycol 3350
4. Perrigo Confirms Filing for Generic Version of Mens Rogaine(R) Foam
5. Perrigo Company Will Release First Quarter Fiscal 2010 Results on November 2, 2009
6. Perrigo Company Announces Dividend Increase
7. Perrigo Company Announces Quarterly Dividend
8. Perrigo Company Will Release Second Quarter Fiscal 2010 Results on February 2, 2010
9. Perrigo Company to Present at the 28th Annual J.P. Morgan Healthcare Conference
10. Perrigo Company To Present at the Sidoti Emerging Growth Conference
11. Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com ... available in its catalogue: The Market ... http://www.reportlinker.com/p02051938/The-Market-for-Medical-Devices-in-EMEA .html The European, Middle Eastern and ... medical devices. As part of its coverage, this ... concentrates on the EMEA medical device markets and ...
(Date:8/20/2014)... Aug 20, 2014 Reportlinker.com announces that ... its catalogue: Global Patient Scales Industry ... This report analyzes the worldwide markets for Patient ... Segments: Floor Scales, Infant & Baby Scales, Chair ... separate comprehensive analytics for the US, Canada, Japan, ...
(Date:8/20/2014)... 20, 2014 Glenmark Pharmaceuticals ... Pharmaceuticals Limited India (GPL), announces the discovery and ... clinical development candidate, GBR 1302, a HER2xCD3 bispecific ... the Glenmark Biologics Research Centre located in La ... is based on Glenmark,s innovative BEAT antibody technology ...
Breaking Medicine Technology:The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 2Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody 3
... Risk Frontline Elderly AML and in Combination with Cytarabine in Relapsed/Refractory ... for Tuesday, December 9 at 11:00 am ET to Discuss Phase ... , SAN FRANCISCO , Dec. 7 Sunesis ... of new data from two ongoing clinical trials demonstrating that the ...
... Dec. 6 Results from RESTORE 2, a,placebo-controlled, Phase ... the number of seizures in adult,patients with refractory partial-onset ... added to a patient,s current anti-epileptic drug (AED) therapy. ... experiencing,seizures despite taking stable doses of up to three ...
Cached Medicine Technology:Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 2Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 3Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 4Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 5Sunesis Pharmaceuticals Announces Presentation of Voreloxin Clinical Data in Patients with Acute Myeloid Leukemia at the 50th Annual Meeting of the American Society of Hematology 6Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 2Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 3Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 4Retigabine Significantly Reduces the Number of Seizures in Adults With Inadequately Controlled Partial-Onset Epilepsy 5
(Date:8/21/2014)... 2014 Teen substance abuse is long been ... The rising numbers of young adults falling victim to a ... a difference in the community, the new Troubled Teens Boca ... teens seeking to overcome something like teenage alcohol abuse ... teens find the best teen recovery facility to focus on ...
(Date:8/21/2014)... Drake University’s Phi Gamma Delta (FIJI) and Colleen’s ... research, according to Billy Cundiff, President of Colleen’s Dream ... the Cleveland Browns, says the money raised by the ... Foundation and will fund research to be conducted by ... of Gynecologic Oncology at the University of Iowa’s Holden ...
(Date:8/21/2014)... 21, 2014 Today, Fecbek.com, a leading ... new designs of wedding dresses. And all these elegant, ... designed by excellent designers. , A wedding dress or ... during a wedding ceremony. Color, style and ceremonial importance ... culture of the wedding participants. In order to satisfy ...
(Date:8/20/2014)... Skmen.com, the popular online supplier of men’s and ... party dresses online. Along with this, the company has ... all the fresh products are offered with great discounts and ... special offer before August 31. , Skmen.com has more ... A large proportion of its clothes are selling well in ...
(Date:8/20/2014)... NJ (PRWEB) August 21, 2014 ... Practitioners, today announced that Ethan Nadelmann, JD, PhD, ... Dr. Nadelmann is the founder and executive director ... in the United States promoting alternatives to the ... drug policy reform, both domestically and internationally, he ...
Breaking Medicine News(10 mins):Health News:New Helpline Provides Hope for Troubled Teens in Boca Raton 2Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 2Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 3Health News:Elegant Wedding Dresses Are for Sale at Fecbek.com 2Health News:Skmen.com: New Designs Of Mini Party Dresses Provided Online 2Health News:PAINWeek Welcomes Ethan Nadelmann, JD, PhD, as Keynote Speaker at 2014 Conference 2
... ANTONIO - Breast cancer is a multifaceted disease requiring ... adjuvant therapies. Data presented at the CTRC-AACR San Antonio ... Hormone Supplements Reduce Death from Breast Cancer , ... have been implicated in increased rates of breast cancer, ...
... are victorious in sham SEIU vote , Less ... while caregivers file over 125,000 protests , ... in a statewide vote of healthcare workers conducted by the ... workers overwhelmingly oppose their national union,s sham election. Ballots were ...
... shows , , FRIDAY, Dec. 12 (HealthDay News) -- ... their breast cancer returning after surgery may make ... difficult, a new study concludes. , Doctors typically ... on a standard risk-assessment tool, with four different ...
... just announced her resignation as President of the Texas Medical ... power by the TMB against good physicians. Kalafut,s tenure ... and stonewalling by the TMB and Governor Rick Perry. , ... said AAPS Executive Director Jane Orient. "AAPS has received ...
... for America,s Health (TFAH) commends the Institute of Medicine for their ... Century: Charting a New Course for a Healthier America ... federal government is responsible for protecting the health of Americans, but ... fixed," said Jeff Levi, PhD, Executive Director of TFAH. "The ...
... 12th annual holiday gala The,Teddy Bear Ball, The ... Steve,Mosko, President of Sony Pictures Television in recognition ... with special needs. Grammy(R),winning singer-songwriter Kenny Loggins electrified ... Heart. Long standing friend and colleague of,nearly 30 ...
Cached Medicine News:Health News:Patient management: Quality of life and beyond 2Health News:Free Choice? Not For SEIU Members in California 2Health News:Risk Info for Breast Cancer Patients Too Confusing 2Health News:AAPS Applauds the Resignation of TMB President Roberta Kalafut, Mari Robinson Should Resign Next 2Health News:Trust for America's Health Applauds New IOM Report on Improving the U.S. Department of Health and Human Services for the 21st Century 2Health News:The Help Group's Teddy Bear Ball Salutes Sony Pictures Television President, Steve Mosko and Features Performance by Kenny Loggins 2
... Freedom leg bags are part ... a versatile line of leg bags, ... the varied needs of our customers. ... several sizes, and constructed of 100% ...
... are part of the Freedom Urinary ... leg bags, kits, and accessories designed ... our customers. These leg bags are ... of 100% latex-free soft, textured medical ...
... line of Personal Catheters® ... you would choose for ... configurations - standard, antibacterial, ... - are based on ...
The Antibacterial Personal Catheter® features a unique silicone composition that provides an antibacterial coated soft outer layer of silicone combined with a firm inner layer....
Medicine Products: